نتایج جستجو برای: dlbcl lymphoma

تعداد نتایج: 102737  

Journal: :Blood 2015
Kieron Dunleavy Wyndham H Wilson

Primary mediastinal B-cell lymphoma (PMBL) is a subtype of diffuse large B-cell lymphoma (DLBCL) that is putatively derived from a thymic B cell. Accounting for up to 10% of cases of DLBCL, this subtype predominantly affects women in the third and fourth decades of life. Its clinical and molecular characteristics are distinct from other subtypes of DLBCL and, in fact, closely resemble those of ...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2015
J Y Hong D H Yoon C Suh J Huh I-G Do I Sohn J Jo S-H Jung M E Hong H Yoon Y H Ko S J Kim W S Kim

BACKGROUND Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly is defined only in adults older than 50 years. However, EBV-positive DLBCL can affect younger patients. We investigated the prevalence, clinical characteristics and survival outcomes of EBV-positive DLBCL in young adults. PATIENTS AND METHODS We analyzed patients with de novo DLBCL who were regis...

Journal: :International journal of clinical and experimental pathology 2015
Haige Ye Lu Lu Bei Ge Shenmeng Gao Yongyong Ma Bin Liang Kang Yu Kaiyan Yang

Mixed linage leukemia gene 2 (MLL2) is identified as a novel mutation gene in diffuse large B cell lymphoma (DLBCL). However, the significance of MLL2 protein expression for the prognosis of DLBCL is unclear. In this study, we detected MLL2 protein expression in primary gastrointestinal diffuse large B cell lymphoma (PGI-DLBCL) samples by using tissue microarray immunohistochemistry, and analyz...

Journal: :Oncology reports 2014
Jingjing Wang Yang Zhang Xianling Liu Jinan Ma Ping Liu Chunhong Hu Guangsen Zhang

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma worldwide. Although patient outcomes have significantly improved to a greater than 40% cure rate by the combinatorial cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy, which is widely used, resistance to the CHOP regimen continues to pose a problem in managing or curing DLBCL. Wh...

2013
Georg Lenz

Diffuse large B-cell lymphoma (DLBCL) represents the most frequent lymphoma subtype and is considered a heterogeneous diagnostic category [1]. Using gene expression profiling, two major molecular subtypes termed germinal centre B-cell-like (GCB) DLBCL and activated B-cell-like (ABC) DLBCL can be distinguished [2]. Their gene expression profiles suggest that they arise from B-cells at different ...

Journal: :Hematological Oncology 2023

Introduction: N-acetyltransferase 10 (NAT10) is the only confirmed regulator to mediate N4-acetylcytidine (ac4C) modification of mRNA and crucial for stability translation efficiency. However, its role in diffuse large B-cell lymphoma (DLBCL) development prognosis has not yet been explored. Herein, we explored functional significance regulatory mechanism NAT10 mediated ac4C DLBCL, which expecte...

Journal: :International journal of oncology 2008
Peter Mu-Hsin Chang Po-Min Chen Shie-Liang Hsieh Cheng-Hwai Tzeng Jin-Hwang Liu Tzeon-Jye Chiou Wei-Shu Wang Chueh-Chuan Yen Jyh-Pyng Gau Muh-Hwa Yang

The soluble decoy receptor 3 (DcR3) is a member of the TNF receptor superfamily. It is regarded as a decoy receptor released from tumor cells to escape host immune response by neutralizing the cytotoxic and immunomodulatory effects of FasL, LIGHT and TL1A. Overexpression of DcR3 has been observed in several human malignancies; however, only limited information exists on the role of DcR3 in non-...

2015
Chi Young Ok Qing Ye Ling Li Ganiraju C. Manyam Lijuan Deng Rashmi R. Goswami Xiaoxiao Wang Santiago Montes-Moreno Carlo Visco Alexandar Tzankov Karen Dybkaer Li Zhang Jeremy Abramson Aliyah R. Sohani April Chiu Attilio Orazi Youli Zu Govind Bhagat Kristy L. Richards Eric D. Hsi William W.L. Choi J. Han van Krieken Jooryung Huh Maurilio Ponzoni Andrés J.M. Ferreri Shanxiang Zhang Ben M. Parsons Mina Xu Michael B. Møller Jane N. Winter Miguel A. Piris Zijun Y. Xu-Monette L. Jeffrey Medeiros Ken H. Young

Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly (EBV+ DLBCL-e) is a molecularly distinct variant of DLBCL, characterized by a monoclonal B-cell proliferation that occurs in patients >50 years of age without a history or clinicopathologic evidence of immunodeficiency. However, patients with EBV+ DLBCL younger than 50-years-old also exist in Western countries. We evaluate...

Journal: :Cancer research 2004
Hiroyuki Tagawa Shinobu Tsuzuki Ritsuro Suzuki Sivasundaram Karnan Akinobu Ota Yoshihiro Kameoka Miyuki Suguro Keitaro Matsuo Motoko Yamaguchi Masataka Okamoto Yasuo Morishima Shigeo Nakamura Masao Seto

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma and exhibits aggressive and heterogeneous clinical behavior. To genetically characterize DLBCL, we established our own array-based comparative genomic hybridization and analyzed a total of 70 cases [26 CD-positive (CD5+) DLBCL and 44 CD5-negative (CD5-) DLBCL cases]. Regions of genomic aberrations observed i...

2017
Kouta Sakamoto Tsuyoshi Sekizuka Taeko Uehara Tsunekazu Hishima Sohtaro Mine Hitomi Fukumoto Yuko Sato Hideki Hasegawa Makoto Kuroda Harutaka Katano

Epstein-Barr virus (EBV) encodes 49 microRNAs (miRNAs) in the BART and BHRF1 regions of its genome. Although expression profiles of EBV-encoded miRNAs have been reported for EBV-positive cell lines and nasopharyngeal carcinoma, to date there is little information about total miRNA expression, including cellular and viral miRNAs, in the primary tumors of EBV-associated B-lymphoproliferative diso...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید